Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.4900 (-1.5%) ($12.3700 - $12.8000) on Tue. Aug. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 42 | Latest Price | $12.4900(-1.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.5% a day on average for past five trading days. | Weekly Trend | HALO declines -1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(54%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.16% in a week (0% probabilities). VIXM(-13%) UUP(-11%) TLT(-6%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $13.11 | 5 Day Moving Average | $12.91(-3.25%) | 10 Day Moving Average | $13.14(-4.95%) | 20 Day Moving Average | $13.11(-4.73%) | To recent high | -16.1% | To recent low | 5.8% | Market Cap | $1.707b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |